
Novo Nordisk's Wegovy Sales Surge 85% But Compounded Weight Loss Drugs In US Impacts Annual Outlook
Novo Nordisk A/S NVO on Wednesday reported first-quarter 2025 sales of roughly $10.89 billion (78.09 billion Danish kroner), missing the consensus of $11.64 billion. Sales increased by 19% in Danish kroner and 18% at CER. In U.S. Operations, sales …